96 related articles for article (PubMed ID: 7391520)
1. Catecholaminergic interactions in the regulation of thyrotropin (TSH) secretion in man.
Scanlon MF; Rodriguez-Arnao MD; Pourmand M; Shale DJ; Weightman DR; Lewis M; Hall R
J Endocrinol Invest; 1980; 3(2):125-9. PubMed ID: 7391520
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic modulation of circadian thyrotropin rhythms and thyroid hormone levels in euthyroid subjects.
Scanlon MF; Weetman AP; Lewis M; Pourmand M; Rodriguez-Arnao MD; Weightman DR; Hall R
J Clin Endocrinol Metab; 1980 Dec; 51(6):1251-6. PubMed ID: 7440694
[TBL] [Abstract][Full Text] [Related]
3. The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.
Eskildsen PC; Kirkegaard CB
J Endocrinol Invest; 1985 Oct; 8(5):427-31. PubMed ID: 3935709
[TBL] [Abstract][Full Text] [Related]
4. Copulsatile release of thyrotropin and prolactin in normal and hypothyroid subjects.
Samuels MH; Veldhuis J; Ridgway EC
Thyroid; 1995 Oct; 5(5):369-72. PubMed ID: 8563474
[TBL] [Abstract][Full Text] [Related]
5. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
Foord SM; Peters JR; Dieguez C; Jasani B; Hall R; Scanlon MF
Endocrinology; 1984 Jul; 115(1):407-15. PubMed ID: 6428863
[TBL] [Abstract][Full Text] [Related]
7. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic influence on thyrotropin secretion in primary hypothyroidism.
Reddy S; Bhansali A; Sialy R; Masoodi S; Dutta P; Bhadada S; Dash R
Horm Metab Res; 2005 May; 37(5):286-9. PubMed ID: 15971151
[TBL] [Abstract][Full Text] [Related]
9. Evidence for dopaminergic control of thyrotrophin secretion in man.
Scanlon MF; Weightman DR; Mora B; Heath M; Shale DJ; Snow MH; Hall R
Lancet; 1977 Aug; 2(8035):421-3. PubMed ID: 70641
[TBL] [Abstract][Full Text] [Related]
10. Dopamine is a physiological regulator of thyrotrophin (TSH) secretion in normal man.
Scanlon MF; Weightman DR; Shale DJ; Mora B; Heath M; Snow MH; Lewis M; Hall R
Clin Endocrinol (Oxf); 1979 Jan; 10(1):7-15. PubMed ID: 436307
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic control of circadian and pulsatile pituitary thyrotropin release in women.
Rossmanith WG; Mortola JF; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1988 Sep; 67(3):560-4. PubMed ID: 3410940
[TBL] [Abstract][Full Text] [Related]
12. Analysis of pulsatile secretion of thyrotropin and growth hormone in the hypothyroid rat.
Bruhn TO; McFarlane MB; Deckey JE; Jackson IM
Endocrinology; 1992 Dec; 131(6):2615-21. PubMed ID: 1446603
[TBL] [Abstract][Full Text] [Related]
13. Alpha 1-adrenoreceptors and alpha 1-adrenoreceptor-mediated thyrotropin release in cultures of euthyroid and hypothyroid rat anterior pituitary cells.
Dieguez C; Foord SM; Peters JR; Hall R; Scanlon MF
Endocrinology; 1985 Aug; 117(2):624-30. PubMed ID: 2990855
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor blockade induced by metoclopramide and thyroid-stimulating hormone secretion in man.
Barreca T; Magnani G; Sannia A; Rolandi E
Horm Res; 1981; 14(4):201-8. PubMed ID: 7308978
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic control of thyrotropin, alpha-subunit, thyrotropin beta-subunit, and prolactin in euthyroidism and hypothyroidism: dissociated responses to dopamine receptor blockade with metoclopramide in hypothyroid subjects.
Scanlon MF; Chan V; Heath M; Pourmand M; Rodriguez-Arnao MD; Weightman DR; Lewis M; Hall R
J Clin Endocrinol Metab; 1981 Aug; 53(2):360-5. PubMed ID: 7251818
[No Abstract] [Full Text] [Related]
16. Effects of metoclopramide on fasting-induced TSH suppression.
Samuels MH; Kramer P
Thyroid; 1996 Apr; 6(2):85-9. PubMed ID: 8733877
[TBL] [Abstract][Full Text] [Related]
17. On the role of dopamine receptors in the naloxone-induced hormonal changes in man.
Delitala G; Devilla L; Musso NR
J Clin Endocrinol Metab; 1983 Jan; 56(1):181-4. PubMed ID: 6847869
[TBL] [Abstract][Full Text] [Related]
18. Low thyroxine levels in some hyperprolactinemic patients due to dopaminergic suppression of thyrotropin.
Holdaway IM; Evans MC; Sheehan A; Ibbertson HK
J Clin Endocrinol Metab; 1984 Oct; 59(4):608-13. PubMed ID: 6434574
[TBL] [Abstract][Full Text] [Related]
19. The anti-oestrogen tamoxifen does not interfere with the dopaminergic control of prolactin and TSH release in normogonadotrophic oligozoospermic man.
van Bergeijk L; Gooren LJ
Horm Metab Res; 1986 Apr; 18(4):272-6. PubMed ID: 3086201
[TBL] [Abstract][Full Text] [Related]
20. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
Röjdmark S
J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
